Elantas Beck India closes trading window from July 1

1 min read     Updated on 17 Jun 2026, 04:33 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Elantas Beck India Ltd has closed its trading window from July 1, 2026, until 48 hours after the Q1FY27 results announcement, adhering to SEBI insider trading regulations. The Board meeting date to approve the unaudited results for the quarter and half year ended June 30, 2026, is pending. Designated persons and insiders are prohibited from trading equity shares during this period.

powered bylight_fuzz_icon
43239809

*this image is generated using AI for illustrative purposes only.

Elantas Beck India Ltd has closed its trading window for designated persons, their immediate relatives, and other insiders effective July 1, 2026. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct. The restriction is implemented to regulate, monitor, and report trading in the company's securities during the period leading up to financial results.

The trading window will remain closed until 48 hours after the announcement or declaration of the unaudited financial results for the quarter and half year ending June 30, 2026. The company has stated that the specific date for the Board meeting to approve these results will be intimated in due course. All designated persons have been advised not to deal in the equity shares of the company during this closure period.

Key Details

Parameter Details
Trading Window Closure Start Date July 1, 2026
Reopening Date 48 hours after Q1FY27 results announcement
Reporting Period Quarter and half year ended June 30, 2026
Regulatory Reference SEBI (Prohibition of Insider Trading) Regulations, 2015

The communication was addressed to BSE Limited and signed by Ashutosh Bhanchandra Kulkarni, Head Legal & Company Secretary. The company has ensured that all relevant insiders are notified of the prohibition on trading activities during this specified timeframe.

Historical Stock Returns for Elantas Beck

1 Day5 Days1 Month6 Months1 Year5 Years
+1.08%+13.81%+17.54%+14.74%+14.74%+14.74%

What market expectations are forming regarding Elantas Beck's Q1 FY27 performance given the early trading window closure?

How might the upcoming Board meeting and results announcement impact the stock's volatility once the trading window reopens?

Are there any strategic initiatives or sector trends expected to influence the company's financial results for the quarter ending June 30, 2026?

Elantas Beck India Approves ₹56 Crore Investment to Expand Ankleshwar Manufacturing Capacity

1 min read     Updated on 02 Jun 2026, 05:37 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Elantas Beck India's Board of Directors approved a ₹56 crore investment on June 02, 2026, to expand manufacturing capacity at its Ankleshwar plant in Gujarat by 11,000 MT/year over the existing 35,000 MT/year. The plant currently operates at 90% utilization, and the expansion — to be completed within 12 months and financed through internal accruals — aims to enhance flexibility, reduce bottlenecks, and strengthen supply reliability.

powered bylight_fuzz_icon
41942607

*this image is generated using AI for illustrative purposes only.

Elantas Beck India has approved an investment of ₹56 crore to expand the manufacturing capacity at its Ankleshwar plant in Gujarat. The Board of Directors approved the decision at a meeting held on June 02, 2026. The expansion aims to enhance manufacturing flexibility, reduce operational bottlenecks, and strengthen supply reliability for key product segments to support future business growth.

Expansion at Ankleshwar Plant

The Ankleshwar plant currently operates at a high utilization rate of 90%, necessitating the capacity addition. The project involves an additional capacity of 11,000 MT/year over the existing 35,000 MT/year, increasing the facility's scale to meet rising demand. The expansion is scheduled to be completed within 12 months, subject to necessary regulatory approvals, and will be financed entirely through internal accruals.

The following table outlines the key particulars of the expansion project:

Particulars: Details — Ankleshwar Plant
Existing Capacity: 35,000 MT/year
Existing Capacity Utilization: 90%
Proposed Capacity Addition: 11,000 MT/year
Completion Timeline: 12 months
Investment Required: ₹56 crore (approx.)
Mode of Financing: Internal accruals

Regulatory Compliance

The Board meeting commenced at 02.30 p.m. (IST) and concluded at 03.50 p.m. (IST). The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Elantas Beck

1 Day5 Days1 Month6 Months1 Year5 Years
+1.08%+13.81%+17.54%+14.74%+14.74%+14.74%

How will the additional 11,000 MT capacity impact Elantas Beck India's market share in the specialty chemicals sector?

What are the expected revenue and profit margin contributions once the expansion is fully operational?

Will the company explore further capacity expansions or acquisitions to sustain long-term growth?

More News on Elantas Beck

1 Year Returns:+14.74%